Aker BioMarine ASA – Notice of exercise of call option

Aker BioMarine ASA (OSE:AKBM) has today notified Nordic Trustee AS of the exercise of its call option for the outstanding bonds in the bond issue “FRN Senior Secured NOK 2,000,000,000 Bonds 2024/2027” (ISIN NO0013326025), and each Bondholder is hereby given notice thereof.

The exercise of the call option is conditional upon certain conditions as set out in the Call Option Notice being satisfied or waived no later than by 25 March 2026.

Subject to satisfaction of the aforementioned conditions by no later than 25 March 2026, the entire bond issue will be repaid at 102.125% of the Nominal Amount (plus accrued and unpaid interests on the redeemed amount), with settlement date 30 March 2026 (being the date falling 10 Business Days after the date of the Call Option Notice).

For information relating to the exercise of the Call Option, reference is made to the attached call notice.

For further information, please contact Katrine Klaveness, CFO Mobile: +47 991 58 915 Email: Katrine.klaveness@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to MAR Article 19 and Section 5-12 of the Norwegian Securities Trading Act.

About Aker BioMarine: Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.